Schachna et al. [120] performed immunoblots with cell lysates from scleroderma patients with and without digital loss; staining for GzmB autoantigens was positive in 84% of patients with digital loss, compared to 40% without digital loss. This evidence concerns the gene GZMB and scleroderma.